Press Releases from SpinDiag GmbH (5 total)
Spindiag seeks strategic investors for 15-min POC multiplex PCR system amid prel …
Spindiag GmbH invites strategic investors to join in on its innovation of a 15-minute point-of-care multiplex PCR system amid preliminary insolvency proceedings
Freiburg/Breisgau, Germany, July 10, 2023 - Spindiag GmbH, a start-up company in the field of molecular in-vitro diagnostics, has announced the opening of preliminary insolvency proceedings as a result of challenging market conditions caused by the rapid decline of COVID-19 testing. The company remains operational and is actively seeking…
Freiburg based Spindiag GmbH and Hahn-Schickard research institute receive six m …
The Economic Committee of Baden-Wuerttemberg's Ministry for Economic Affairs, Labour and Housing Construction approved of funding in fast track authorisation
Nested PCR test for results in about 35 minutes directly at the point of care
Freiburg im Breisgau, April 7, 2020 - Spindiag GmbH, based in Freiburg im Breisgau, is a medical technology start-up that arose out of the renowned Hahn-Schickard Institute for Microanalytical Systems four years ago. Together with Hahn-Schickard, the…
Spindiag’s continued road to success: Expansion of Series A with an additional …
- With new and current investors, the medtech startup in Freiburg takes the next big step in launching its innovative technology for the rapid detection of multidrug-resistant bacteria.
- The additional money will enable industrializing the production and securing CE-IVD approval for the EU market of an MRSA (methicillin-resistant Staphylococcus aureus) rapid test planned for launch in 2020.
- A recent study on the usability of Spindiag’s point-of-care system confirms its easy,…
SpinDiag closes second financing round of EUR 3.0 million (USD 3.4 million) to c …
Freiburg im Breisgau, Germany / November 2018 – One year after its seed financing, SpinDiag GmbH closes a second financing round of EUR 3 million (USD 3.4 million) as planned. The financing will enable SpinDiag to complete the product development of its first product for screening for antibiotic-resistant bacteria and to start clinical trials. This will pave the way for regulatory approval in the EU.
To finance the current Series A,…
SpinDiag Raises 1.6 Mio. € To Bring Point-of-Care Screening For Antibiotic Res …
The Freiburg-based startup SpinDiag GmbH recently closed a 1.6 Mio. EUR seed-round with three private investors. The team developed a revolutionary point-of-care screening system for testing patients for antibiotic-resistant bacteria at their admission to hospitals and almost instantly so. The seed-capital will make it feasible to bring SpinDiag’s system from its current laboratory environment to first tests in hospitals. “Testing in hospitals will not only be an important milestone for…
